COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 569: Articles 5681-5690  | Next

Epidemiology and outcomes of SARS-CoV-2 infection associated with anti-nucleocapsid seropositivity in Cape Town, South Africa
Hussey, H., Vreede, H., Davies, M.-A., Heekes, A., Kalk, E., Hardie, D. R., Van Zyl, G., Naidoo, M., Morden, E., Bam, J.-L., Zinyakatira, N., Centner, C., Maritz, J., Opie, J., Chapanduka, Z., Mahomed, H., Smith, M., Cois, A., Pienaar, D., Redd, A., Preiser, W., Wilkinson, R. J., Chetty, K., Boulle, A., Hsiao, N.-y. M.
10.1101/2022.12.01.22282927 — Posted: 2022-12-05
SARS-CoV-2 infection- induced seroprevalence among children and associated risk factors during pre- and omicron-dominant wave, from January 2021 through November 2022, Thailand: Longitudinal study
Suntronwong, N., Vichaiwattana, P., Klinfueng, S., Puenpa, J., Kanokudom, S., Assawakosri, S., Chansaenroj, J., Srimuan, D., Thatsanatorn, T., Songtaisarana, S., Sudhinaraset, N., Wanlapakorn, N., Poovorawan, Y.
10.1101/2022.12.01.22283006 — Posted: 2022-12-05
Enhancing the sensitivity of rapid antigen detection test (RADT) of different SARS-CoV-2 variants and lineages using fluorescence-labeled antibodies and a fluorescent meter
Nasrallah, G., Ali, F., Younes, S., AlKhatib, H., Althani, A., YASSINE, H. M.
10.1101/2022.12.04.22283067 — Posted: 2022-12-05
Low Dimensional Chaotic Attractors in Daily Hospital Occupancy from COVID-19 in the USA and Canada
Goncalves, C. P. d. S.
10.1101/2022.12.04.22283069 — Posted: 2022-12-05
Increased insulin resistance due to Long COVID is associated with depressive symptoms and partly predicted by the inflammatory response during acute infection
Kadhem Al-Hakeim, H., Tahseen Al-Rubaye, H., S. Jubran, A., Almulla, A. F., Moustafa, S., Maes, M.
10.1101/2022.12.01.22283011 — Posted: 2022-12-04
Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database
The OpenSAFELY Collaborative, , Zheng, B., Campbell, J., Carr, E. J., Tazare, J., Nab, L., Mahalingasivam, V., Mehrkar, A., Santhakumaran, S., Steenkamp, R., Loud, F., Lyon, S., Scanlon, M., Hulme, W. J., Green, A. C., Curtis, H. J., Fisher, L., Parker, E., Goldacre, B., Douglas, I., Evans, S., MacKenna, B., Bell, S., Tomlinson, L., Nitsch, D., The LH&W NCS (or CONVALESCENCE) Collaborative
10.1101/2022.12.02.22283049 — Posted: 2022-12-04
Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection?
Reddy, N. V., Yeh, H.-C., Tronieri, J. S., Sturmer, T., Buse, J. B., Reusch, J. E., Johnson, S. G., Wong, R., Moffitt, R. A., Wilkins, K. J., Harper, J., Bramante, C. T.
10.1101/2022.12.02.22283029 — Posted: 2022-12-04
Durability of immune responses to the booster mRNA vaccination against COVID-19
S Arunachalam, P., Lai, L., Samaha, H., Feng, Y., Hu, M., Hui, H. S.-y., Wali, B., Ellis, M., Huerta, C., Bechnack, K., Bechnack, S., Lee, M., Litvack, M., Losada, C., Grifoni, A., Sette, A., Zarnitsyna, V. I., Rouphael, N., Suthar, M. S., Pulendran, B.
10.1101/2022.12.02.22282921 — Posted: 2022-12-04
Evaluating primary and booster vaccination prioritization strategies for COVID-19 by age and high-contact employment status using data from contact surveys
Roubenoff, E. M., Feehan, D., Mahmud, A. M.
10.1101/2022.12.02.22283040 — Posted: 2022-12-04
The Societal Value of Vaccines: Expert-Based Conceptual Framework and Methods Using COVID-19 Vaccines as A Case Study
Di Fusco, M., Mendes, D., Steuten, L., Bloom, D. E., Drummond, M., Hauck, K., Pearson-Stuttard, J., Power, R., Salisbury, D., Towse, A., Roiz, J., Szabo, G., Yang, J., Marczell, K.
10.1101/2022.12.02.22283046 — Posted: 2022-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).